home / stock / hims / hims news


HIMS News and Press, Hims & Hers Health Inc. Class A From 05/20/24

Stock Information

Company Name: Hims & Hers Health Inc. Class A
Stock Symbol: HIMS
Market: NYSE
Website: forhims.com

Menu

HIMS HIMS Quote HIMS Short HIMS News HIMS Articles HIMS Message Board
Get HIMS Alerts

News, Short Squeeze, Breakout and More Instantly...

HIMS - Hims & Hers surges on cheap compounded versions of Novo Nordisk's semaglutide

2024-05-20 10:15:35 ET More on Hims & Hers Health 10 Solid Reasons To Buy Hims & Hers Stock Hims & Hers: Strong Operating Leverage And Profitability Inflection Hims & Hers: The Growth Story, Coupled With Expanding Profitability, Promises Exponential G...

HIMS - Hims & Hers surges on cheap compounded versions of Novo Nordisk's semagluitide

2024-05-20 10:11:34 ET More on Hims & Hers Health 10 Solid Reasons To Buy Hims & Hers Stock Hims & Hers: Strong Operating Leverage And Profitability Inflection Hims & Hers: The Growth Story, Coupled With Expanding Profitability, Promises Exponential G...

HIMS - US Companies Moving the Markets, Morning edition
Mon, May 20, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 37.1% to $0.2344 on volume of 300,511,226 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 78.2% to $1.835 on volume of 218,102,513 shares Greenwave Technology Solutions Inc. (GWAV) r...

HIMS - Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers

Hims & Hers unlocks access to injectable GLP-1 medications, expanding its holistic weight loss program focused on personalized and affordable solutions; prices start as low as $199 a month Hims & Hers Health, Inc., the leading health and wellness platform, today announced the ad...

HIMS - Is Hims & Hers Health Stock a Buy?

2024-05-13 04:37:00 ET Telehealth company Hims & Hers Health (NYSE: HIMS) found itself immersed in controversy recently after some polarizing social media posts by the company's CEO sparked debate. The stock took a bit of a hit as a result Then the company released first-quarter...

HIMS - Goldman screens for growth stocks with a near-term path to profitability

2024-05-12 13:57:40 ET More on the markets SPY ETF: Momentum Is In The Cards SPY: Get Ready For A Recessionary Bear Market SPY: Growing Signs The Market Is Overbought Wells Fargo sees increasing risk that the Fed will need to hold rates at current levels ...

HIMS - (HIMS) Investment Analysis and Advice

2024-05-11 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HIMS - Hims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?

2024-05-11 03:15:00 ET Shares of Hims & Hers Health (NYSE: HIMS) jumped following the company's first-quarter earnings report that once again announced surging revenue growth. That performance has helped the stock perform well this year, up about 40%. Let's look at some rece...

HIMS - 10 Solid Reasons To Buy Hims & Hers Stock

2024-05-09 07:36:42 ET Summary It's been a wild week for HIMS stock — CEO Andrew Dudum said a few things that upset investors. H&H also reported blowout earnings, sending shares higher. People quickly forget that H&H is a brilliant company. I share with you ...

HIMS - Hims & Hers: Strong Operating Leverage And Profitability Inflection

2024-05-08 10:44:13 ET Summary Hims & Hers is showing strong operating leverage and maintaining high growth, which should continue in future quarters. The CEO's recent tweets on the Israel/Gaza situation are unfortunate from an investor perspective, but the business impact is ...

Previous 10 Next 10